Immune Design Corp. — Form D/A

Immune Design Corp. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2014-06-11. The offering totals $11K, of which $11K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Steven ReedDirectorMichigan CIty, IN
Steven ReedExecutive OfficerMichigan CIty, IN
Brian AtwoodDirectorSouth San Francisco, CA
David BaltimoreDirectorSan Diego, CA
James Paul RickeyExecutive OfficerSeattle, WA
Richard KlausnerDirectorSouth San Francisco, CA
Sammy FarahExecutive OfficerNew York, NY
PETER V SVENNILSONDirectorSAN FRANCISCO, CA
Paul T RickeyExecutive OfficerSeattle, WA
William T RingoDirectorSeattle, WA
Jan Henrik T ter MeulenExecutive OfficerSeattle, WA
Brian V AtwoodDirectorSeattle, WA
Alain V SchreiberDirectorSeattle, WA
Bruce V CarterDirectorSeattle, WA
Wayne R GombotzExecutive OfficerSeattle, WA
James T RickeyExecutive OfficerSeattle, WA
Ed V PenhoetDirectorSeattle, WA
Richard T KenneyExecutive OfficerSeattle, WA
Carlos V PayaDirectorSeattle, WA
Carlos V PayaExecutive OfficerSeattle, WA
Stephen R BradyExecutive OfficerSeattle, WA
David V BaltimoreDirectorSeattle, WA
Wayne Paul GombotzExecutive OfficerSeattle, WA
Bruce LA CarterDirectorSeattle, WA
Roger V PerlmutterDirectorSeattle, WA

Other filings by this issuer (10)

FiledFormOfferingSold
2014-06-12D$18K$18K
2014-06-11D$10$10
2013-10-31D$57.8M$48.5M
2013-01-30D/A$34.0M$34.0M
2011-10-05D/A$34.0M$23.4M
2010-08-26D/A$34.0M$12.7M
2010-08-05D$32.0M$12.0M
2009-10-06D$11K$11K
2009-07-29D$14K$14K
2009-07-08D/A$18.0M$14.0M

More